Pamela F. Schwartz - Concepedia

Concepedia

Author

Pamela F. Schwartz

Pfizer (United States)

Also Known As

P F Schwartz, P. F. Schwartz, Pamela F. Schwartz, Pamela Schwartz

40

Publications

1.8K

Citations

17

H-Index

29

Concepts

All Affiliations

Pfizer (United States)Virginia Commonwealth University Medical Center The Schwarzman Animal Medical Center Brigham and Women's Hospital Harvard University

PF

About

Pamela F. Schwartz is an author at Pfizer (United States) specializing in medicine, reproductive health, and environmental health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	96
2	Management	2	2	54
3	Public Health	2	2	54
4	Biostatistics	2	2	54
5	Health Sciences	1	1	16

Pamela F. Schwartz

×

25

Publications

1.8K

Citations

17

H-Index

	Year	Citations
Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients Paul M. Ridker, James H. Revkin, Pierre Amarenco, New England Journal of Medicine	2017	623
Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab Paul M. Ridker, Jean‐Claude Tardif, Pierre Amarenco, New England Journal of Medicine	2017	355
Evaluation of prognostic factors in the surgical treatment of adrenal gland tumors in dogs: 41 cases (1999–2005) Pamela F. Schwartz, Janet R. Kovak, Alexandra Koprowski, Journal of the American Veterinary Medical Association	2008	109
A Prospective, Randomized, Masked, and Placebo-Controlled Efficacy Study of Intraarticular Allogeneic Adipose Stem Cells for the Treatment of Osteoarthritis in Dogs Robert J. Harman, Kim Carlson, Jamie S. Gaynor, Frontiers in Veterinary Science	2016	99
Evaluating bococizumab, a monoclonal antibody to PCSK9, on lipid levels and clinical events in broad patient groups with and without prior cardiovascular events: Rationale and design of the Studies of PCSK9 Inhibition and the Reduction of vascular Events (SPIRE) Lipid Lowering and SPIRE Cardiovascular Outcomes Trials Paul M. Ridker, Pierre Amarenco, Robert Brunell, American Heart Journal	2016	64
Ponezumab in mild‐to‐moderate Alzheimer's disease: Randomized phase II PET‐PIB study Jaren W. Landen, Niels Andreasen, Carol Cronenberger, Alzheimer s & Dementia Translational Research & Clinical Interventions	2017	63
Tracking of Left Ventricular Mass in Children: Race and Sex Comparisons Richard M. Schieken, Pamela F. Schwartz, Monica Martin Goble Circulation	1998	62
Multiple‐dose ponezumab for mild‐to‐moderate Alzheimer's disease: Safety and efficacy Jaren W. Landen, Sharon Cohen, Clare B. Billing, Alzheimer s & Dementia Translational Research & Clinical Interventions	2017	59
Childhood passive smoking, race, and coronary artery disease risk: the MCV Twin Study. Medical College of Virginia. William B. Moskowitz, Pamela F. Schwartz, Richard M. Schieken PubMed	1999	45
Threshold Models for Combination Data from Reproductive and Developmental Experiments Pamela F. Schwartz, Chris Gennings, Vernon M. Chinchilli Journal of the American Statistical Association Breeding BehaviorFertilityNational Toxicology ProgramReproductive HealthExposure Assessment	1995	43

Page 1